News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
TMX Newsfile
NEWS
IN THE PRESS
Business
Global Hemp Group Announces the Appointment of Arelio Useche and Veronique Laberge to the Company’s Board of Directors
February 14, 2023
·
4 min read
BioHarvest Sciences Announces Clinical Study in Patients with Multiple Sclerosis-Related Optic Neuritis
February 14, 2023
·
5 min read
Awakn Life Sciences Announces the Opening of Its Fourth Clinic
February 14, 2023
·
5 min read
Khiron Closes Revolving Credit Facility with Financing Company in Colombia
February 14, 2023
·
4 min read
Nova Mentis Granted Health Canada Section 56 Exemption to Begin Psilocybin Clinical Trial
February 14, 2023
·
4 min read
Drug Development
NervGen Pharma Announces Completion of Dosing of All Subjects in Phase 1 Clinical Trial of Proprietary Drug Candidate NVG-291
February 14, 2023
·
6 min read
PharmaDrug Announces Plans for First-In-Human Clinical Study with PD-001 (Enteric-Coated Cepharanthine -2HCL) in Esophageal Cancer
February 13, 2023
·
14 min read
Drug Development
Skye Bioscience Doses Second Cohort of Phase 1 Clinical Trial of SBI-100 Ophthalmic Emulsion
February 13, 2023
·
5 min read
BioHarvest Sciences Reports 2022 Sales Orders of USD 6.1M Representing 2.6X Increase over 2021
February 9, 2023
·
6 min read
Awakn Life Sciences Responds to OTC Markets Request on Recent Promotional Activity
February 9, 2023
·
6 min read
15 Toronto St., Suite 601 Toronto ON M5C 2E3 US
Tel: 416-806-1750
Visit website
Email Us